[English] 日本語
Yorodumi- PDB-8ywq: Crystal structure of the Fab fragment of the anti-IL-6 antibody I... -
+
Open data
-
Basic information
| Entry | Database: PDB / ID: 8ywq | ||||||
|---|---|---|---|---|---|---|---|
| Title | Crystal structure of the Fab fragment of the anti-IL-6 antibody I9H in complex with a domain-swapped IL-6 dimer | ||||||
Components |
| ||||||
Keywords | IMMUNE SYSTEM / interleukin / dimer / swap | ||||||
| Function / homology | Function and homology informationregulation of astrocyte activation / glucagon secretion / positive regulation of interleukin-21 production / regulation of glucagon secretion / hepatic immune response / negative regulation of primary miRNA processing / regulation of vascular endothelial growth factor production / negative regulation of interleukin-1-mediated signaling pathway / regulation of microglial cell activation / interleukin-6 receptor complex ...regulation of astrocyte activation / glucagon secretion / positive regulation of interleukin-21 production / regulation of glucagon secretion / hepatic immune response / negative regulation of primary miRNA processing / regulation of vascular endothelial growth factor production / negative regulation of interleukin-1-mediated signaling pathway / regulation of microglial cell activation / interleukin-6 receptor complex / positive regulation of apoptotic DNA fragmentation / hepatocyte proliferation / positive regulation of type B pancreatic cell apoptotic process / neutrophil apoptotic process / germinal center B cell differentiation / positive regulation of extracellular matrix disassembly / response to peptidoglycan / interleukin-6 receptor binding / positive regulation of B cell activation / positive regulation of receptor signaling pathway via STAT / T-helper 17 cell lineage commitment / inflammatory response to wounding / positive regulation of T-helper 2 cell cytokine production / endocrine pancreas development / negative regulation of collagen biosynthetic process / regulation of neuroinflammatory response / positive regulation of acute inflammatory response / vascular endothelial growth factor production / negative regulation of chemokine production / T follicular helper cell differentiation / positive regulation of neuroinflammatory response / positive regulation of leukocyte chemotaxis / positive regulation of platelet aggregation / neutrophil mediated immunity / positive regulation of cytokine production involved in inflammatory response / cell surface receptor signaling pathway via STAT / positive regulation of leukocyte adhesion to vascular endothelial cell / negative regulation of bone resorption / CD163 mediating an anti-inflammatory response / positive regulation of peptidyl-tyrosine phosphorylation / positive regulation of immunoglobulin production / Interleukin-6 signaling / interleukin-6-mediated signaling pathway / negative regulation of fat cell differentiation / MAPK3 (ERK1) activation / maintenance of blood-brain barrier / MAPK1 (ERK2) activation / Interleukin-10 signaling / positive regulation of interleukin-17 production / monocyte chemotaxis / humoral immune response / Transcriptional Regulation by VENTX / positive regulation of interleukin-10 production / positive regulation of vascular endothelial growth factor production / positive regulation of glial cell proliferation / negative regulation of lipid storage / positive regulation of peptidyl-serine phosphorylation / regulation of angiogenesis / cell surface receptor signaling pathway via JAK-STAT / positive regulation of osteoblast differentiation / positive regulation of epithelial to mesenchymal transition / : / positive regulation of chemokine production / positive regulation of T cell proliferation / positive regulation of smooth muscle cell proliferation / liver regeneration / regulation of insulin secretion / response to glucocorticoid / positive regulation of translation / cytokine activity / positive regulation of interleukin-1 beta production / acute-phase response / response to activity / positive regulation of interleukin-8 production / positive regulation of receptor signaling pathway via JAK-STAT / Post-translational protein phosphorylation / growth factor activity / neuron cellular homeostasis / cellular response to virus / platelet activation / negative regulation of neurogenesis / positive regulation of interleukin-6 production / positive regulation of miRNA transcription / cellular response to hydrogen peroxide / Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) / cytokine-mediated signaling pathway / neuron projection development / positive regulation of tumor necrosis factor production / ADORA2B mediated anti-inflammatory cytokines production / glucose homeostasis / cellular response to lipopolysaccharide / Senescence-Associated Secretory Phenotype (SASP) / Interleukin-4 and Interleukin-13 signaling / defense response to Gram-negative bacterium / defense response to virus / positive regulation of MAPK cascade / defense response to Gram-positive bacterium / positive regulation of apoptotic process / endoplasmic reticulum lumen / inflammatory response Similarity search - Function | ||||||
| Biological species | Homo sapiens (human) | ||||||
| Method | X-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 2.51 Å | ||||||
Authors | Bukhdruker, S. / Yudenko, A. / Marin, E. / Remeeva, A. / Rodin, S. / Burtseva, A. / Petrov, A. / Ischenko, A. / Borshchevskiy, V. | ||||||
| Funding support | Russian Federation, 1items
| ||||||
Citation | Journal: Structure / Year: 2025Title: Structural basis of signaling complex inhibition by IL-6 domain-swapped dimers. Authors: Yudenko, A. / Bukhdruker, S. / Shishkin, P. / Rodin, S. / Burtseva, A. / Petrov, A. / Pigareva, N. / Sokolov, A. / Zinovev, E. / Eliseev, I. / Remeeva, A. / Marin, E. / Mishin, A. / ...Authors: Yudenko, A. / Bukhdruker, S. / Shishkin, P. / Rodin, S. / Burtseva, A. / Petrov, A. / Pigareva, N. / Sokolov, A. / Zinovev, E. / Eliseev, I. / Remeeva, A. / Marin, E. / Mishin, A. / Gordeliy, V. / Gushchin, I. / Ischenko, A. / Borshchevskiy, V. | ||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 8ywq.cif.gz | 261.7 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb8ywq.ent.gz | 187.5 KB | Display | PDB format |
| PDBx/mmJSON format | 8ywq.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Summary document | 8ywq_validation.pdf.gz | 447 KB | Display | wwPDB validaton report |
|---|---|---|---|---|
| Full document | 8ywq_full_validation.pdf.gz | 449.4 KB | Display | |
| Data in XML | 8ywq_validation.xml.gz | 23.1 KB | Display | |
| Data in CIF | 8ywq_validation.cif.gz | 29.8 KB | Display | |
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/yw/8ywq ftp://data.pdbj.org/pub/pdb/validation_reports/yw/8ywq | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 8ywpSC ![]() 8ywrC ![]() 1aluS S: Starting model for refinement C: citing same article ( |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
-
Assembly
| Deposited unit | ![]()
| ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ![]()
| ||||||||||||
| Unit cell |
| ||||||||||||
| Components on special symmetry positions |
|
-
Components
| #1: Antibody | Mass: 24912.051 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Production host: ![]() |
|---|---|
| #2: Antibody | Mass: 23396.971 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Production host: ![]() |
| #3: Protein | Mass: 21005.961 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: IL6, IFNB2 / Cell line (production host): HEK293 / Production host: Homo sapiens (human) / References: UniProt: P05231 |
| #4: Chemical | ChemComp-MG / |
| #5: Water | ChemComp-HOH / |
| Has ligand of interest | N |
| Has protein modification | Y |
-Experimental details
-Experiment
| Experiment | Method: X-RAY DIFFRACTION / Number of used crystals: 1 |
|---|
-
Sample preparation
| Crystal | Density Matthews: 2.63 Å3/Da / Density % sol: 53.28 % |
|---|---|
| Crystal grow | Temperature: 293 K / Method: vapor diffusion, sitting drop / pH: 10.5 Details: 40% v/v 2-methyl-2,4-pentanediol, 100 mM CAPS (seed stock crystallization conditions: 14-16% PEG 8000, 100 mM magnesium acetate, 100 mM MES pH 6.5) |
-Data collection
| Diffraction | Mean temperature: 100 K / Serial crystal experiment: N |
|---|---|
| Diffraction source | Source: SYNCHROTRON / Site: SLS / Beamline: X06SA / Wavelength: 0.85 Å |
| Detector | Type: DECTRIS EIGER X 16M / Detector: PIXEL / Date: Nov 19, 2019 |
| Radiation | Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray |
| Radiation wavelength | Wavelength: 0.85 Å / Relative weight: 1 |
| Reflection | Resolution: 2.51→40.97 Å / Num. obs: 14890 / % possible obs: 91.7 % / Redundancy: 13 % / Biso Wilson estimate: 89.68 Å2 / CC1/2: 0.999 / Rpim(I) all: 0.031 / Net I/σ(I): 11.2 |
| Reflection shell | Resolution: 2.51→2.82 Å / Redundancy: 12.3 % / Mean I/σ(I) obs: 0.7 / Num. unique obs: 744 / CC1/2: 0.098 / Rpim(I) all: 1.411 / % possible all: 69.3 |
-
Processing
| Software |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Refinement | Method to determine structure: MOLECULAR REPLACEMENTStarting model: 1ALU,8YWP Resolution: 2.51→40.97 Å / SU ML: 0.3274 / Cross valid method: FREE R-VALUE / σ(F): 1.33 / Phase error: 40.8304 Stereochemistry target values: GeoStd + Monomer Library + CDL v1.2
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Solvent computation | Shrinkage radii: 0.9 Å / VDW probe radii: 1.1 Å / Solvent model: FLAT BULK SOLVENT MODEL | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Displacement parameters | Biso mean: 89.35 Å2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement step | Cycle: LAST / Resolution: 2.51→40.97 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refine LS restraints |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LS refinement shell |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement TLS params. | Method: refined / Refine-ID: X-RAY DIFFRACTION
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement TLS group | Refine-ID: X-RAY DIFFRACTION
|
Movie
Controller
About Yorodumi



Homo sapiens (human)
X-RAY DIFFRACTION
Russian Federation, 1items
Citation


PDBj


























